Real-Time News FIRE NOW SIP Calculators

Easy-to-understand Financial Insights
that build Wealth.

Suit Of Products

Explore Dzambhala Pro

Biocon Biologics' Insulins Facility in Malaysia Inspected by US FDA, Receives Form 483 Observations

Sept. 28, 2024, 5:18 p.m.

The US FDA conducted a cGMP (current Good Manufacturing Practice) inspection at Biocon Biologics’ Insulins Manufacturing Facility in Johor Bahru, Malaysia from September 17 to September 27, 2…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

BIOCON Regulatory